Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.49 |
| ▸ | RAD52 | P43351 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8669263 | 0.93 | NAAA (0.60) | NAAANPSR1RAD52MAPK1FAAH | |
| SCHEMBL29361575 | 0.88 | NAAA (0.55) | NAAANPSR1RAD52MAPK1FAAH | |
| SCHEMBL27712380 | 0.88 | NAAA (0.55) | NAAANPSR1RAD52MAPK1FAAH | |
| SCHEMBL30871928 | 0.88 | NAAA (0.55) | NAAANPSR1RAD52MAPK1FAAH | |
| SCHEMBL27489586 | 0.88 | NAAA (0.55) | NAAANPSR1RAD52MAPK1CA2 | |
| SCHEMBL28010016 | 0.88 | NAAA (0.55) | NAAANPSR1RAD52MAPK1FAAH | |
| SCHEMBL20893678 | 0.88 | NAAA (0.58) | NAAANPSR1RAD52MAPK1CA2 | |
| SCHEMBL27578440 | 0.87 | NAAA (0.53) | NAAANPSR1RAD52MAPK1CA2 | |
| SCHEMBL27619677 | 0.86 | NAAA (0.52) | NAAANPSR1RAD52MAPK1FAAH | |
| SCHEMBL27657744 | 0.86 | MAPK1 (0.40) | NAAANPSR1RAD52MAPK1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11844850-B2 | Water in oil type cosmetic composition for preventing syneresis | SHISEIDO COMPANY, LTD. (JP) | 2023-12-19 | — | — | US | disclosed |
| US-20230044107-A1 | WATER IN OIL TYPE EMULSION COSMETIC | SHISEIDO COMPANY, LTD. (JP) | 2023-02-09 | — | — | US | disclosed |
| US-20220287934-A1 | COMPOSITION FOR EXTERNAL APPLICATION | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2022-09-15 | — | — | US | disclosed |
| EP-4026534-A1 | COMPOSITION FOR EXTERNAL APPLICATION | Rohto Pharmaceutical Co., Ltd. (JP) | 2022-07-13 | — | — | EP | disclosed |
| EP-3763354-A1 | SYNERESIS-PREVENTING WATER-IN-OIL-TYPE COSMETIC COMPOSITION | Shiseido Company, Ltd. (JP) | 2021-01-13 | — | — | EP | disclosed |
| US-20210000706-A1 | WATER IN OIL TYPE COSMETIC COMPOSITION FOR PREVENTING SYNERESIS | SHISEIDO COMPANY, LTD. (JP) | 2021-01-07 | — | — | US | disclosed |
| EP-3542783-A1 | OILY COMPOSITION AND OILY COSMETIC | Shiseido Company Ltd. (JP) | 2019-09-25 | — | — | EP | disclosed |
| US-20190262252-A1 | OIL BASED COMPOSITION AND OIL BASED COSMETIC | SHISEIDO COMPANY, LTD. (JP) | 2019-08-29 | — | — | US | disclosed |
| CN-103387675-B | Block type modified organopolysiloxane, its use and manufacture method, cosmetic | 信越化学工业株式会社 | 2016-09-28 | — | — | CN | disclosed |
| EP-2689772-B1 | SOLID COSMETIC | SHISEIDO CO LTD (JP) | 2016-08-10 | — | — | EP | disclosed |
| US-8198335-B2 | Cosmetic material | PARAHERMOSA CO., LTD. (JP) | 2012-06-12 | — | — | US | disclosed |
| EP-2450029-A1 | EXTERNAL PREPARATION FOR THE SKIN | Shiseido Co., Ltd. (JP) | 2012-05-09 | — | — | EP | disclosed |
| EP-2172185-B1 | Cosmetic material comprising octyl hydroxy stearate oligomer | PARAHERMOSA CO LTD (JP) | 2011-11-23 | — | — | EP | disclosed |
| US-20100087551-A1 | COSMETIC MATERIAL | PARAHERMOSA CO., LTD. (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-2172185-A2 | Cosmetic material comprising octyl hydroxy stearate oligomer | Parahermosa Co., Ltd. (JP) | 2010-04-07 | — | — | EP | disclosed |
| US-20080319084-A1 | Wrinkling Prevention or Remedy with Adam Activity Inhibiting Substance | SHISEIDO COMPANY, LTD. (JP) | 2008-12-25 | — | — | US | disclosed |
| US-7393400-B2 | Non-aqueous ink composition for ink jet | TOSHIBA TEC KABUSHIKI KAISHA (JP) | 2008-07-01 | — | — | US | disclosed |
| EP-1810656-A1 | PREVENTION OR IMPROVEMENT OF WRINKLES BY USING ADAM ACTIVATION INHIBITOR | Shiseido Company, Limited (JP) | 2007-07-25 | — | — | EP | disclosed |
| US-20070131137-A1 | Non-aqueous ink composition for inkjet | TOSHIBA TEC KABUSHIKI KAISHA | 2007-06-14 | — | — | US | disclosed |
| US-20070022904-A1 | Non-aqueous ink composition for ink jet | TOSHIBA TEC KABUSHIKI KAISHA (JP) | 2007-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080319084-A1 | Wrinkling Prevention or Remedy with Adam Activity Inhibiting Substance | ADAM17, MMP3, MMP14 | NAAA 383/4885NPSR1 895/4885RAD52 1775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.